Amarin to Report Fourth Quarter and Full Year 2016 Results and Host Conference Call on February 28th, 2017
BEDMINSTER, N.J., and DUBLIN, Ireland, Feb. 22, 2017 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, today announced that it will host a conference call with members of Amarin senior management to discuss the company's fourth quarter and full year 2016 financial results and provide an operational update on Tuesday, February 28th, at 7:30 a.m. ET. The conference call will follow the anticipated release of the company's financial results earlier that day.